Becton Dickinson & Co

BDX: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|&>LOCK|$d@&LOCK|##B

Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters

Waters and BD have agreed to combine BD's biosciences and diagnostics unit with Waters. BD will receive $4 billion in cash and a 39.2% stake in the combination. The deal is scheduled to close in the first quarter of 2026. In early trading, Waters shares were down 11% and BD's were down 1%.

Sponsor Center